1cP-AL-LAD
A synthetic psychedelic compound
| 1cP-AL-LAD | |
|---|---|
| |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
1cP-AL-LAD is a synthetic psychedelic compound that belongs to the lysergamide class. It is structurally related to LSD and is known for its psychoactive effects. 1cP-AL-LAD is a derivative of AL-LAD, with a cyclopropylcarbonyl group attached to the nitrogen of the indole ring.
Chemical Structure[edit | edit source]
1cP-AL-LAD is a lysergamide, which means it is a derivative of lysergic acid. The chemical structure of 1cP-AL-LAD includes a cyclopropylcarbonyl group, which is a distinguishing feature from other lysergamides such as LSD and AL-LAD. This modification is believed to affect the compound's pharmacokinetics and pharmacodynamics.
Pharmacology[edit | edit source]
1cP-AL-LAD acts primarily as a partial agonist at the 5-HT2A receptor, which is thought to be responsible for its psychedelic effects. Like other psychedelics, it may also interact with other serotonin receptors, contributing to its overall psychoactive profile. The exact mechanism of action and the full spectrum of its effects are still under investigation.
Effects[edit | edit source]
The effects of 1cP-AL-LAD are similar to those of other psychedelics, such as LSD and psilocybin. Users report altered perceptions, visual hallucinations, and changes in thought processes. The onset of effects typically occurs within 30 to 90 minutes after ingestion, with the experience lasting between 6 to 10 hours.
Legal Status[edit | edit source]
The legal status of 1cP-AL-LAD varies by country. In some jurisdictions, it may be considered a controlled substance due to its structural similarity to other illegal psychedelics. In others, it may be legal or exist in a legal gray area. Users should be aware of the laws in their specific location before obtaining or using 1cP-AL-LAD.
Safety and Risks[edit | edit source]
As with other psychedelics, the use of 1cP-AL-LAD carries potential risks, including psychological distress, anxiety, and the possibility of triggering latent mental health disorders. It is important for users to approach its use with caution, ideally in a safe and controlled environment.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
